I-domain-antigen conjugate (IDAC) for delivering antigenic peptides to APC: synthesis, characterization, and in vivo EAE suppression
about
Codelivery of antigen and an immune cell adhesion inhibitor is necessary for efficacy of soluble antigen arrays in experimental autoimmune encephalomyelitisVaccinelike and prophylactic treatments of EAE with novel I-domain antigen conjugates (IDAC): targeting multiple antigenic peptides to APCSynthesis of a Bifunctional Peptide Inhibitor-IgG1 Fc Fusion That Suppresses Experimental Autoimmune Encephalomyelitis.
P2860
I-domain-antigen conjugate (IDAC) for delivering antigenic peptides to APC: synthesis, characterization, and in vivo EAE suppression
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
I-domain-antigen conjugate (ID ...... n, and in vivo EAE suppression
@ast
I-domain-antigen conjugate (ID ...... n, and in vivo EAE suppression
@en
type
label
I-domain-antigen conjugate (ID ...... n, and in vivo EAE suppression
@ast
I-domain-antigen conjugate (ID ...... n, and in vivo EAE suppression
@en
prefLabel
I-domain-antigen conjugate (ID ...... n, and in vivo EAE suppression
@ast
I-domain-antigen conjugate (ID ...... n, and in vivo EAE suppression
@en
P2093
P2860
P356
P1476
I-domain-antigen conjugate (ID ...... n, and in vivo EAE suppression
@en
P2093
Ahmed H Badawi
Barlas Büyüktimkin
Nadezhda A Galeva
Paul Kiptoo
Prakash Manikwar
Teruna J Siahaan
Todd D Williams
P2860
P304
P356
10.1021/BC200580J
P577
2012-03-12T00:00:00Z